Firms
Theme

PPAETF

Invesco Aerospace & Defense ETF · NYSE ARCA

News

7 latest

The Motley Fool

Lower Fees, Higher Growth: Why Cost-Conscious Aerospace Investors May Favor XAR Over PPA

XAR and PPA are aerospace and defense ETFs with different strategies. XAR uses a modified equal-weight approach with a lower 0.35% expense ratio and has delivered stronger 5-year returns (112% vs 81%), making it more appealing to cost-conscious investors. PPA uses market-cap weighting, has higher fees at 0.58%, but offers a higher dividend yield of 0.4% versus XAR's 0.2%.

Zacks Investment Research

Should You Invest in the Select STOXX Europe Aerospace & Defense ETF (EUAD)?

The Select STOXX Europe Aerospace & Defense ETF (EUAD) received a Zacks ETF Rank of 4 (Sell) and is not recommended for investors seeking aerospace and defense exposure. The ETF has underperformed with a 2.9% loss year-to-date and 7.92% decline over the past year. With concentrated holdings and a 0.5% expense ratio, better alternatives like Invesco Aerospace & Defense ETF (PPA) and iShares U.S. Aerospace & Defense ETF (ITA) are suggested.

The Motley Fool

The Defense ETF Duel: Old Guard Aerospace or Next-Gen Tech?

Invesco Aerospace & Defense ETF (PPA) and First Trust Indxx Aerospace & Defense ETF (MISL) offer different approaches to defense sector investing. PPA, the larger and more established fund with $7.4B in AUM, delivers higher dividends (0.4% yield) and lower volatility with traditional aerospace exposure.

Zacks Investment Research

Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?

The State Street SPDR S&P Aerospace & Defense ETF (XAR) is analyzed as a smart beta ETF with $5.52 billion in assets and a low expense ratio of 0.35%. However, the fund has underperformed recently, declining 5.84% year-to-date and 8.96% over the past year as of October 9, 2026.

Zacks Investment Research

Should You Invest in the First Trust Indxx Aerospace & Defense ETF (MISL)?

The First Trust Indxx Aerospace & Defense ETF (MISL) offers diversified exposure to the aerospace and defense sector with a 0.6% expense ratio and $771.54 million in assets. The ETF has declined 2.46% year-to-date and 3.32% over the past year, with top holdings including Palantir Technologies, RTX Corporation, and SpaceX. MISL received a Zacks ETF Rank of 2 (Buy), though larger competitors like ITA and PPA offer lower expense ratios.

Mentions PPA

Zacks Investment Research

Defense ETFs in Spotlight Ahead of Q3 Earnings Season

The U.S. defense sector experienced a nearly 19% decline from early August through mid-October 2026 due to rising Treasury yields, military spending uncertainty ahead of midterms, and supply-chain constraints. Despite headwinds, the Aerospace sector is expected to report 11.8% earnings growth supported by NATO spending commitments and strong backlogs. Key defense contractors like Lockheed Martin and RTX are scheduled to report Q3 results, with investors focusing on cash flow generation and contract execution amid a higher cost of capital environment.

Zacks Investment Research

Boeing Lands $20B Navy Deal for Next-Gen Fighter Jet: ETFs to Watch

Boeing won a $20 billion contract from the U.S. Navy to develop the sixth-generation F/A-XX Strike Fighter, beating Northrop Grumman. The company also secured a $2.38 billion contract for additional F-15EX aircraft and received major commercial orders from Turkish Airlines (150 737 MAX jets) and Korean Air (103 aircraft).

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $PPA · 0 threads

Sign in to post on $PPA

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev